← Open Payments lookup

AMY JACKSON: Open Payments

NPI 1972866085 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$792 in 32 payments from 15 companies in 2025. Trend: 2023 $290 · 2024 $555 · 2025 $792

Food & beverage: $792
CompanyPaymentsAmount
Alkermes, Inc.11$325
Luye Pharma (USA) Ltd.3$139
Teva Pharmaceuticals USA, Inc.3$59
Otsuka America Pharmaceutical, Inc.3$49
Novo Nordisk Inc2$41
Neos Therapeutics, LP1$22
Neurocrine BioSciences, Inc.1$21
Novartis Pharmaceuticals Corporation1$20
Amgen Inc.1$18
ABBVIE INC.1$18

Products named: ARISTADA, ERZOFRI EXTENDED-RELEASE, LYBALVI, UZEDY, Ozempic, REXULTI, Adzenys XR-ODT, INGREZZA.

Industry payments across IN — which companies pay providers there.